Durable polymers used for first-generation drug-eluting stents (DES) potentially contribute to persistent inflammation and late DES thrombosis. We report the first in human experience with the rapamycin-eluting biodegradable polymer coated cobalt-chromium FIREHAWK^® stent with abluminal groove. ...

The study sought to compare long-term optical coherence tomography (OCT)-based in-stent vascular response between the abluminal groove-filled biodegradable polymer sirolimus-eluting stent (SES) and the durable polymer everolimus-eluting stent (EES) in the TARGET I trial. ...

初步探索 Firehawk^®雷帕霉素药物洗脱支架在临床应用中的效益分析。 方法：回顾2015年1月至2015年12月期间分别接受 Firehawk^®支架及 Fierbird 2^®支架介入治疗的89例冠心病患者,通过分析对比一般情况、介入相关情况及随访相关指标,初步探索 Firehawk^®雷帕霉素药物洗脱支架在临床应用中的安全性及疗效。 ...

观察雷帕霉素洗脱支架Firebird 2™ 置入治疗无保护左主干严重狭窄病变冠心病的安全性和有效性。...

The emergence of drug-eluting stents(DES)has dramatically reduced the incidence of in-stent restenosis.This study was conducted to evaluate the safety and and efficacy of sirolimus-eluting cobalt-chrome stents(Firebird 2)for treating patients with coronary artery disease....